Publications by authors named "VERONICA Bordin"

Claim this Profile
A
Anti-epidermal growth factor receptor skin toxicity: a matter of topical hydration.
Daris Ferrari, Carla Codecà, Barbara Bocci, Francesca Crepaldi, Martina Violati, Veronica Bordin

Anticancer Drugs· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Italian Survey on adjuvant treatment of non-small cell lung cancer (ISA).
Giuseppe Luigi Banna, Massimo Di Maio, Alessandro Follador, Elena Collovà, Jessica Menis, Veronica Bordin

Lung Cancer· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II study of carboplatin and paclitaxel for recurrent or metastatic head and neck cancer.
Daris Ferrari, Jessica Fiore, Carla Codecà, Giuseppe Di Maria, Samuela Bozzoni, Veronica Bordin

Anticancer Drugs· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduction of cisplatin-induced anemia by the pineal indole 5-methoxytryptamine in metastatic lung cancer patients.
Paolo Lissoni, Fabio Malugani, Roberta Bukovec, Veronica Bordin, Maristella Perego

Neuro Endocrinol Lett· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new neuroimmunotherapeutic strategy of subcutaneous low-dose interleukin-2 plus the long-acting opioid antagonist naltrexone in metastatic cancer patients progressing on interleukin-2 alone.
Paolo Lissoni, Fabio Malugani, Veronica Bordin, Ario Conti, George Maestroni

Neuro Endocrinol Lett· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of bicalutamide therapy on prolactin response to L-dopa in metastatic prostate cancer patients.
Paolo Lissoni, Fabio Malugani, Marilena Casu, Roberta Bukovec, Remo Egardi, Veronica Bordin

Neuro Endocrinol Lett· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Malignancy: Changes in Circulating Immature and Mature Dendritic Cells During IL-2 Cancer Immunotherapy and Their Relation with Lymphocyte Increase and Clinical Response.
PAOLO Lissoni, ANGELA Bonfanti, VERONICA Bordin, SANDRO Barni, LUIGI Vigore

Hematology· January 2000

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis